Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage
Alice-Maria Toader,Marion K. Campbell,Jennifer K. Quint,Michael Robling,Matthew R Sydes,Joanna Thorn,Alexandra Wright-Hughes,Ly-Mee Yu,Tom. E. F. Abbott,Simon Bond,Fergus J. Caskey,Madeleine Clout,Michelle Collinson,Bethan Copsey,Gwyneth Davies,Timothy Driscoll,Carrol Gamble,Xavier L. Griffin,Thomas Hamborg,Jessica Harris,David A. Harrison,Deena Harji,Emily J. Henderson,Pip Logan,Sharon B. Love,Laura A. Magee,Alastair O’Brien,Maria Pufulete,Padmanabhan Ramnarayan,Athanasios Saratzis,Jo Smith,Ivonne Solis-Trapala,Clive Stubbs,Amanda Farrin,Paula Williamson
DOI: https://doi.org/10.1186/s13063-024-07926-z
IF: 2.728
2024-01-31
Trials
Abstract:Healthcare system data (HSD) are increasingly used in clinical trials, augmenting or replacing traditional methods of collecting outcome data. This study, PRIMORANT, set out to identify, in the UK context, issues to be considered before the decision to use HSD for outcome data in a clinical trial is finalised, a methodological question prioritised by the clinical trials community.
medicine, research & experimental